title: Development of diffuse alopecia with psoriasis-like eruptions during administration of infliximab for Crohn's disease.
authors.forename: Kousaku
authors.initials: K
authors.lastname: Kawashima
authors.forename: Shunji
authors.initials: S
authors.lastname: Ishihara
authors.forename: Akiko
authors.initials: A
authors.lastname: Yamamoto
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Ohno
authors.forename: Kosuke
authors.initials: K
authors.lastname: Fukuda
authors.forename: Koji
authors.initials: K
authors.lastname: Onishi
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Kinoshita
mesh_terms: D000505:Alopecia / Q000139:chemically induced* / Q000150:complications; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000139:chemically induced* / Q000150:complications; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000069285:Infliximab